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Abstract: Electrospray ionization mass spectrometry has become invaluable in the 
characterization of macromolecular biological systems such as nucleic acids and proteins. 
Recent advances in the field of mass spectrometry and the soft conditions characteristic  
of electrospray ionization allow for the investigation of non-covalent interactions among 
large biomolecules and ligands. Modulation of genetic processes through the use of  
small molecule inhibitors with the DNA minor groove is gaining attention as a potential 
therapeutic approach. In this review, we discuss the development of a competition method 
using electrospray ionization mass spectrometry to probe the interactions of multiple  
DNA sequences with libraries of minor groove binding molecules. Such an approach acts  
as a high-throughput screening method to determine important information including the 
stoichiometry, binding mode, cooperativity, and relative binding affinity. In addition to small 
molecule-DNA complexes, we highlight other applications in which competition mass 
spectrometry has been used. A competitive approach to simultaneously investigate complex 
interactions promises to be a powerful tool in the discovery of small molecule inhibitors with 
high specificity and for specific, important DNA sequences. 
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The continued development of electrospray ionization (ESI) methods and the extensive improvements 
in commercial mass spectrometry (MS) instruments over the last two decades have brought ESI-MS 
experiments into the forefront of analysis of biomacromolecules and their complexes. The majority of 
ESI-MS (electrospray ionization mass spectrometry) reports on biological systems to date have involved 
proteins but nucleic acids are attracting increasing attention. Early studies on double helical DNA involved 
establishing conditions for preserving the duplex in the gas phase and evaluating different volatile solution 
buffers/salts for optimum ESI-MS conditions [1]. There are numerous reports on duplex stability [1–3], 
dissociation to single strands [4–6], effects of ESI conditions [7,8], solution composition [9–12] and 
nucleic acid sequence [13,14]. These key studies and more have provided a strong foundation for ESI 
experiments on nucleic acid-small molecule complexes. 
1.1. Small Molecule Studies by ESI-MS 
The early studies on ESI-MS requirements for stable duplex (for example Smith and  
co-workers [1,15]) quickly evolved into important studies on DNA complexes with metal ions [5,16], 
organic compounds [17–22] and proteins [23]. The studies of organic systems complement extensive 
solution biophysical studies that have two important goals: (i) develop a better understanding of the 
fundamental features of nucleic acid interactions and (ii) design nucleic acid targeting agents for 
biotechnology and therapeutics. Compounds that bind in the DNA minor groove have a variety of 
structural features that affect their affinity, stoichiometry and sequence specificity. All of these features, 
as well as cooperativity for compounds with a stoichiometry greater than one, can be investigated by 
ESI-MS methods. The earliest reports of DNA complex by ESI-MS were with the polyamide minor 
groove binder, distamycin A [15,24]. The complex was intact in the gas phase and gave a 1:1 binding 
stoichiometry for a 12 base pair duplex that had an AAATTT base sequence binding site at low ratios of 
distamycin to DNA complex. As the ratio of distamycin to duplex was increased, a 2:1 bound species 
was observed and these results are in agreement with solution experimental findings [25–27]. The 
excellent agreement between species present and their ratio dependencies was a significant example that 
showed nucleic acid complex stoichiometry, cooperativity and relative affinities could be determined  
by ESI-MS. 
The successful, initial studies of small molecule-DNA complexes moved into ESI-MS experiments 
with a well-known variety of agents, including organic intercalators, such as ethidium bromide [28–30], 
metallo-intercalators [31], bis-intercalators [32,33] and a wide variety of minor groove binders of quite 
different structure [28,34]. All of the results with minor groove binders and intercalators, for which 
solution results were available, were in excellent agreement with the solution studies. It is now quite 
clear that ESI-MS experiments, when properly conducted, will provide complementary and very useful 
results for analysis of DNA-small molecule complexes. The method is quite versatile and experiments 
can be rapidly conducted so that it is an attractive addition to other powerful, biophysical approaches for 
DNA complex analysis. The ability to quickly analyze non-covalent complexes, with good sensitivity 
and low sample consumption, as well as the variety of information provided, makes ESI-MS a very 
valuable tool. 
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1.2. Application to Other Systems 
ESI-MS is often used for characterizing small, organic molecules but has become a powerful tool for 
large biomolecular systems. For small molecule-DNA investigations, excellent consistency using ESI-MS 
and other biophysical methods has been found. Competition ESI-MS is particularly appealing since 
multiple interactions between ligand and DNA can be simultaneously analyzed. Analyzing interactions 
between a single DNA and a single ligand is not efficient for screening a library of compounds. With a 
competition method, a large number of interactions can be studied in much less time than with the 
conventional approach of one DNA and one ligand. Valuable information is gathered quickly with 
regards to preferential binding of a ligand to DNA. Although several of the studies described later will 
focus primarily on the binding of small molecule ligands to DNA, this technique is not limited to these 
specific interactions and can be applicable to other biomolecules of interest, including proteins [2,22,35–38], 
carbohydrates [39,40], and other types of nucleic acids such as RNA [41–51] and peptide nucleic  
acids [52–54]. 
2. Protein Complexes with Nucleic Acids by ESI-MS 
2.1. Transcription Factor Proteins 
The ETS family of transcription factors (TF) comprises a major class of transcriptional regulators 
across many species, including humans [55]. Humans also express various oncogenic mutations of the 
ETS TFs that are associated, for example, with bone, breast, and prostate tumors [56,57]. All ETS TFs 
have similar DNA binding domains that are highly conserved in structure with a 5′-GGAA/T-3′ consensus 
central binding site [58]. Genomic analyses have identified the ETS member PU.1 as a pioneering 
transcription factor [59] that can overcome chromatin packaging to bind chromosomal DNA. The PU.1 
TF is a unique protein, encoded by the SPI1 gene, which has high affinity binding for purine-rich DNA 
motifs, or PU-box. Because of the special properties of PU.1, it is important to understand how DNA 
recognition by PU.1 is differentiated from other ETS proteins. There is, thus, an essential need for a 
broad range of methods and studies, including ESI-MS, to address the physical mechanisms of sequence 
recognition by the PU.1 TF. 
The importance of PU.1 and the many broad-based biophysical and genetic studies on PU.1 [58,60–62] 
made it an attractive choice for early ESI-MS studies to test detection of protein-DNA complexes. The 
goal was to find an additional, powerful method to help understand PU.1-DNA interactions. Smith and 
co-workers [63] used both a gel electrophoretic mobility shift assay (EMSA) and ESI-MS methods  
to characterize the PU.1 association with both a wild type 17 base pair DNA as well as a very similar 
sequence with mutations in the critical GGAA binding site of PU.1. The EMSA analysis showed strong 
binding of PU.1 to the wild type DNA but no detectable binding to the mutant sequence. They developed 
ESI-MS conditions to detect duplexes of both DNA sequences and collected very useful spectra of a 
PU.1 1:1 complex with the wild type DNA. The stability and amount of the protein-DNA complex were 
very impressive, especially for such an early study. They also did a competition binding study of PU.1 
with both the wild type and mutant DNAs. In very encouraging results, which are in excellent agreement 
with the EMSA experiments, no significant mutant complex could be detected, even in the presence  
of a large excess of the mutant DNA. This result clearly shows the power of ESI-MS to characterize  
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protein-DNA complexes and resolve differences in binding affinity that are in good agreement with other 
biophysical studies. 
2.2. Protein Inhibition 
Targeting TF-DNA complexes, either for inhibition or enhancement, is very attractive for the 
treatment of a number of different diseases. This could be done by targeting the TF or the DNA binding 
domain. Unfortunately, it has proved very difficult to target TFs and they are frequently referred to as 
“undruggable” [64,65]. An alternative is to target the DNA binding domain of the TF with designed 
small molecules and this approach is gaining increasing attention. As described above, ESI-MS has 
developed into a very attractive method to evaluate both small molecule binding to specific DNA 
sequences as well as for their effects on TF-DNA complexes. Ralph, Beck and co-workers conducted  
a very impressive illustrative example of this approach with the PU.1 protein-DNA complex [66]. They 
combined the PU.1 DNA binding site with the critical GGAA sequence along with the PU.1 DNA 
binding domain. In the positive ion ESI-MS mode, conditions were developed with the PU.1-DNA 
complex as the major species and small peaks for the free DNA and PU.1. They noted that similar results 
were also obtained in the negative ion mode. They next added Ru and Pt based DNA intercalators to the 
system and obtained very impressive inhibition results for the PU.1-DNA complex. In a titration of an 
intercalator into the TF-DNA complex, the PU.1-DNA complex peak decreased and peaks for the free 
protein and DNA increased. It is also impressive that they were also able to see peaks for complexes  
of the intercalators to protein-free DNA. They saw no evidence that the intercalator could bind to the 
protein. The wealth of important information obtained in this fairly simple, single experiment clearly 
illustrates the power of ESI-MS in both the characterization of TF-DNA complexes and in the discovery 
and development of TF inhibitors. Although ESI-MS studies of protein-DNA complexes are relatively 
rare, a number of studies have appeared in recent years and it is likely that many more are in progress. 
3. Methods and Notes 
Electrospray ionization mass spectrometry is an ideal method for analysis of biomacromolecules 
because of the versatility and ease it provides in characterizing interactions. Information such as 
stoichiometry, cooperativity, and relative binding affinities are determined quickly within a single 
sample solution at low concentrations. The gentle ionization technique essentially allows non-covalent 
interactions to remain intact. DNA, protein, or any system of interest is injected into the electrospray 
ionization source and directed through a capillary tube at high voltage potential. Depending on the 
applied potential, the solution is then aerosolized into a fine spray of charged droplets. It is believed that 
the solvent evaporates from the presence of a warm, dry stream of an inert gas. While the size of the 
droplet decreases, the charge density on the droplet surface increases. Eventually, the Rayleigh limit, or 
maximum charge density a droplet can have, is reached and the droplet disperses into even smaller 
droplets. This process repeats many times until the solution is evaporated and the formed ions are then 
carried towards the mass analyzer [67,68]. 
The ESI-MS injection process to move samples from the solvation to the gas phase produces charged 
species with multiple charge states during the injection ionization process. Depending on the type of 
species being analyzed, the ion mode analysis may vary from system to system and may depend on  
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the net charge of the largest system present. For instance, when analyzing DNA and small molecule 
interactions, the overall negative net charge of the DNA is greater than the one or two positive charges 
on the small molecules. Therefore, negative ion mode is used for DNA-small molecule analyses. On the 
other hand, if one were to analyze a TF-DNA interaction, depending on the overall charge of the protein, 
negative or positive ion mode can be used. Either ion mode can offer insight into specific interactions 
that the other mode cannot detect [34] and should therefore be considered. It is best to perform 
experiments with both ion modes and different experimental parameters, such as voltages, temperature 
and RF lens tuning, when beginning studies on new systems. 
For every system multiply charged species are found. For small molecule complexes with DNA in 
the under 20 base pair range, the most common charge states of the DNA and their corresponding small 
molecule complexes range from −3 to −6 in negative ion mode. Lower net charges imply the phosphate 
backbone of the DNA becomes partially neutralized during the electrospray process. Ammonium  
acetate is the preferred buffer for ESI-MS analyses in part because of its volatility and its ability to help 
neutralize the backbone. This is believed to occur through a proton transfer from an ammonium ion  
to the DNA backbone and the creation of volatile ammonia. [1,9,24,69] The amount of backbone 
neutralization that occurs varies based on many factors, including but not limited to, DNA size, 
ammonium acetate concentration, and the instrument conditions [28,29,70,71]. It is worth noting that 
although the presence of a positive ligand helps in neutralizing the net charge of the phosphate backbone, 
it typically does not affect the net charge of the DNA-small molecule complex in the gas phase. 
4. Designing Systems for Competition ESI-MS 
In design studies of new, sequence specific compounds to target promoter DNA and inhibit TF 
binding development of a high-throughput screening technique to simultaneously evaluate multiple 
features of small molecule-DNA complex interactions would be a significant advance. In this review  
we will describe progress in ESI-MS for detection of complexes formed between DNA and sequence 
specific minor groove binding compounds. The interactions are screened with a variety of designed, 
synthetic minor groove binders and specific DNA sequences. The complexes are characterized by the 
differences in DNA sequence and/or ligand structure which influence the relative binding affinity, 
stoichiometry, and binding mode(s). This is a true competitive assay since the strongest binding compounds 
will interact with available binding sites first. Secondary or non-specific interactions may then occur 
between sequences and the compound through weaker binding interactions. 
4.1. Hairpin DNA Sequences 
ESI-MS is a mass-specific technique; therefore, there are many considerations in choosing the ligand 
and target DNA sequences. Sequences can be designed so that the base pairs adjacent to, or flanking, the 
target site in the stem are conserved. To do this, a single-stranded DNA sequence is designed which will 
fold back on itself through a self-complementary, intramolecular interaction which results in the 
formation of a loop on one end while the 5′ and 3′ terminal bases are hydrogen bonded at the other end 
(Figure 1). These secondary structures are commonly referred to as hairpin or stem loops, as they tend 
to resemble the loops found in devices used to secure long hair. Hairpin DNAs are the preferred structures 
for many studies as a dsDNA mimetic due to their simplicity (one strand vs. two for complementary strands) 
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and structural stability at high temperatures and in gas phase conditions [72]. Since distinguishable 
molecular weights are necessary for all species and (potential) complexes involved, the hairpin loops 
can also be modified to incorporate different combinations of bases to adjust the molecular weights as 
desired since bases in the loops are not involved in binding interactions. 
The molecular weights of cytidine (C), deoxyuridine (U), and thymine (T) are all different which is 
how the total molecular weight for a hairpin DNA would be adjusted, assuming no other modifications 
were made to the constant stem portion of the DNA. Figure 1 presents an example of how hairpin loop 
modifications offer an advantage to competitive DNA analyses. In Figure 1a, four different sequences 
are combined into a single sample and analyzed by ESI-MS. Let us assume, for all intents and purposes, 
the molecular weights for the DNA sequences are arbitrary and each sequence differs only by the 
addition of a base pair. The peaks for the individual DNAs are illustrated as red, green, black, and blue 
with the red peak corresponding to the lowest molecular weight sequence (x base pairs), green has the 
next lowest molecular weight (x + 1 base pairs), the black DNA has x + 2 base pairs, and the blue peak 
corresponds to a sequence with the highest molecular weight (x + 3 base pairs), shown in Figure 1a. 
Ligand is next added to the sample and DNA-ligand complexes are formed (Figure 1b). Unfortunately, 
the molecular weight of the ligand is similar to that of a base pair, and the molecular weights for the 
DNA-ligand complexes were not predetermined. Figure 1b illustrates a complex formed by ligand and 
red-DNA, but the molecular weight for the complex is the same as the molecular weight for unbound 
black-DNA (no complex). The peaks, therefore, overlap and neither species can be distinguished. 
Now, let us assume the hairpin loops have been adjusted so that regardless if a DNA-ligand complex 
is formed, peaks will not overlap. The loops have been modified so instead of thymidine (5′-TTTT-3′) it 
can become all cytidines (5′-CCCC-3′), contain both cytidine and thymidine (5′-CTTT-3′) or include 
deoxyuridine (5′-TUTU-3′). This type of modification allows the target binding site(s) in the DNA stem 
to be maintained while circumnavigating the issue of overlapping peaks and molecular weights. Now, 
complexes formed between the ligand and red-DNA no longer overlap that of unbound black-DNA and 
become easily distinguishable (Figure 1d). As a side note, modifications are not limited to thymidine, 
cytidine or deoxyuridine and can include halogenated bases, 3′ terminal phosphate additions, etc. The 
important feature is that each base has a unique molecular weight and when combined together act as a 
signature for a specific DNA sequence. A very similar approach has been used by numerous groups to 
investigate DNA quadruplexes formed by folding of a single strand of DNA into a four-stranded 
structure with three connecting loops that can have a wide variety of conformations. There have  
also been numerous uses of ESI-MS to investigate compounds that interact with quadruplexes,  
for example by Beck, Brodbelt, and Gabelica [69,73,74]. 




Figure 1. Cartoon to illustrate the adjustment of hairpin DNAs to achieve different molecular 
weights for ESI-MS studies. Target base pair sites in the stem of the DNA are preserved.  
(a) DNA with unadjusted molecular weights; (b) complex and unbound DNA peaks are  
not distinguishable upon addition of ligand due to overlapping peaks for free DNA and  
DNA-ligand complexes (e.g., black and red); (c) modifications in the hairpin loop by 
incorporation of various bases allows the DNA stem to be preserved while creating 
distinguishable molecular weights; (d) complexes and free DNA become easily identifiable. 
T = thymidine, C = cytidine, U = deoxyuridine. 
4.2. Response & Sensitivity of DNA and DNA-Small Molecule Complexes 
In ESI-MS, as well as other experiments, every analyte (small molecule, DNA, protein, etc.) has its 
own, unique physiochemical properties which contribute to the overall sensitivity or response detected. 
This feature is important to consider in quantitative analyses. Gabelica and co-workers formulated an 
additional fitting parameter, commonly referred to as the response factor, which takes into account 
variations in the sensitivity for each individual species detected [75]. Preservation of the flanking 
sequences and mutation specifically at the target binding site keeps the base pair composition and gives 
similar sensitivities to all of the DNA sequences and their complexes. Due to this, a direct comparison 
of the relative binding affinities and binding modes for the DNA-ligand complexes and free DNA is 
possible so factors, such as response factors, are not a significant limitation for qualitative and  
semi-quantitative analyses. This independence of response factors require careful design of the systems 
being compared, as described above. 
Competitive interactions between several DNA sequences and ligands help to establish an understanding 
of the selectivity for potential drug candidates. One approach to examine selectivity uses a standard 
reference system. For instance, a non-covalent complex with a known binding constant can be included 
in the sample. The peak intensity of the known system can then be directly compared to the unknown 
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species to estimate the relative binding affinities [76]. Wortmann and co-workers determined the  
binding affinities of ligand-protein kinase interactions using a reference system having a known binding 
constant [35]. This example of competition binding by ESI-MS using a known system to determine the 
relative binding affinities of unknown ligands can extend even into fento- and nanomolar ranges. 
Kempen and co-workers also employed a similar method in which the concentrations of a reference 
protein and ligand were held constant, while the concentration of unknown ligand was varied so that the 
binding constants of the unknown ligands were determined [77]. These studies are prime examples for 
using ESI-MS and the addition of an internal standard or reference system to determine apparent binding 
affinities of small molecule and DNA or protein interactions. 
4.3. Limitations in Quantitation of DNA-Small Molecule Complexes 
There are many examples in the literature, for example, by Gabelica and co-workers [75,78] which 
show results obtained by ESI can be accurately quantified. Unfortunately, due to the intrinsic nature  
of dicationic diamidines (and likely with other ligands) analyses can be limited to qualitative and  
semi-quantitative information such as relative binding affinities. Due to their intrinsic properties, some 
ligands will be lost inside the tubing during the injection process, therefore, reducing the total ligand 
concentration. Typically, to remove residual bound or “sticky” compounds, an excess of DNA is  
used to bind the ligand, followed by an extremely thorough cleaning of the instrument. Fortunately, the 
free ligand concentration for binding DNA remains the same within a given sample and encourages 
competitive binding so that preferential binding sites are easily determined. Assuming the KD 
(dissociation constant) is known for a single DNA-small molecule complex, unbound and bound DNA 
complexes can be directly compared for relative binding affinities, and if the stoichiometry is greater 
than 1:1, cooperative or non-specific interactions can also be determined. Theoretically, any number of 
DNA sequences can be screened for binding a particular ligand which greatly reduces the volume of 
reagent(s) used and the amount of time spent cleaning the instrument between runs. 
5. Competition ESI-MS 
Competition ESI-MS is a frequently useful addition to existing ESI-MS techniques because it uses 
multiple substrates (nucleic acids, proteins, etc.) to screen for binding interactions with other species 
(small molecules, proteins, etc.). For example, multiple nucleic acid sequences can be screened to 
evaluate the relative binding affinities, stoichiometries, cooperativity and selectivity with small ligands, 
proteins or both at the same time. Beck and co-workers used a similar approach to investigate the 
competitive binding of a ruthenium compound against daunomycin and distamycin to determine the 
binding mode of the ruthenium to DNA [79]. Many differences in binding have been determined for a 
compound and its analogs using DNA sequences with systematic variations [80,81]. This method has 
been useful in comparing the effects of structural modification to a parent compound and its influence 
on DNA recognition and has become invaluable in identifying the preferred binding sites for a ligand. 
Another approach involves screening relative binding affinities of a set of small molecules with a 
critical nucleic acid sequence. This is especially useful in searching for promising agents for inhibition 
of a TF-nucleic acid complex. This method is advantageous over other screening methods since the 
conditions are soft enough to preserve the complexes formed in solution yet versatile enough to provide 
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a broad array of results for the interaction. Several other groups have explored the ability to probe  
DNA-ligand complexes through the use of multiple small molecules with a DNA sequence. Gabelica 
and co-workers have contributed substantially to this field and helped to pioneer the investigation  
of DNA complexes through ESI-MS. Early ESI-MS competition studies involved the dodecamer 
crystalized by Dickerson and co-workers [82] with standard minor groove binding compounds [28].  
In decreasing order of preferred binding, they were able to identify the relative binding affinities of 
netropsin, distamycin A, DAPI, Hoescht, and berenil to an AT rich sequence in dsDNA by comparing 
the competitive behavior of two compounds at a time. Casagrande and co-workers have also provided 
extensive insights into the competitive binding of small molecules with quadruplex DNA. Calf thymus 
dsDNA was used as an internal competitor to help evaluate the selectivity of coronene and perylene 
compounds to quadruplex DNA [76]. 
In combination with modeling studies, interaction of a ligand with various DNA sequences—based 
on initial ESI-MS data—can aid in designing, synthetic binding agents with improved selectivity and 
specificity for DNA. Many results have shown that competition ESI-MS agrees well with data reported 
by other biophysical techniques, and several examples are described below. All results obtained using 
ESI-MS have been validated by alternative methods including, but not limited to, biosensor-SPR 
(biosensor-surface plasmon resonance), circular dichroism and fluorescence spectroscopy, DNase I 
footprinting and UV thermal melting. 
5.1. Establishing a Competition Method Using Standard Minor Groove Binding Compounds 
Analysis of competitive binding of compounds with a set of multiple, mixed sequence DNA 
sequences by ESI-MS is an attractive method that has been used in a number of applications. Initial tests 
were performed with minor groove binding compounds, netropsin [83–88] and DB75 [89–91], which 
are well-characterized. They are often used as standards in method development with DNA and minor 
groove binding compounds [92,93]. The compounds, as with many common minor groove binders,  
bind specifically to AT sequences. For simplicity, each DNA is denoted by its target site found in the 
sequence. For instance, if the target site in the sequence shown in Figure 2a is AAATTT, it is referred 
to as AAATTT. Additionally, a target site, such as AAATTT, is highlighted with a particular color font, 
in this case as green, and its corresponding peaks (i.e., unbound AAATTT and/or AAATTT-ligand 
complexes) are also color-coded in green. 
Titrations of A-tract and alternating AT sequences that have AAATTT and ATATAT binding  
sites in hairpin duplexes (Figure 2a) are shown with netropsin and DB75 in Figure 2b. At low molar 
concentrations of ligand to DNA, the interactions of a compound with its preferred binding site are 
detectable. For instance, a 1:1 complex formed between netropsin and AAATTT showed a higher peak 
intensity compared to a 1:1 complex formed with AAATTT and DB75 and unbound AAATTT (Figure 2c). 
The differences in peak intensities clearly show that AAATTT is the preferred target site for netropsin 
over ATATAT and this agrees well with other biophysical studies [94]. A relatively weak complex 
formed between a reference sequence (i.e., one which does not contain multiple, adjacent AT base pairs) 
and DB75 was also detected at m/z ≈ 7250 and can occur through intercalation of the compound at GC 
base pair sites. The preferred binding of netropsin to AAATTT continued as concentrations of both 
compounds were increased showing that DB75 is clearly a weaker binding agent than netropsin for both 
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AT-rich sequences. No significant free DNA, with the exception of the reference sequence, was left upon 
reaching a [2:1] molar concentration ratio. 
 
Figure 2. (a) Hairpin DNA sequences used for initial competition ESI-MS studies,  
including reference sequence; (b) Well-studied, classical, adenosine-thymidine (AT) rich, 
base pair-specific minor groove binding compounds netropsin and DB75; (c) spectrum  
of netropsin and DB75 competing for ATATAT and AAATTT sequence binding sites. 
Unbound DNA is unlabeled with corresponding color bar. Respective complexes labeled 
with “N” for netropsin and “D” for DB75. Complexes with both minor groove binding 
compounds are listed as “DN” for each titration. Ratio shown is a molar concentration ratio 
of [2 to 1]. T = thymidine; A = adenosine; G = guanidine; C = cytidine. 
5.2. Applying the Method Using Dimer-Forming Minor Groove Binding Compounds 
The minor groove binding compound, DB293, is an asymmetric dicationic diamidine known to 
recognize both AT-rich and mixed base pair DNA sequences (Figure 3a) [95–98]. It is a special compound 
in several ways, in that its binding mode varies depending on the sequence. DB293 (Figure 3b) is the 
first non-polyamide reported to bind as a dimer to a specific mixed site, GC-containing sequence while 
forming a monomer complex with AT-rich DNA sequences. Recognition of ATGA occurs through 
positive cooperative formation of a stacked dimer. Biosensor-SPR data has shown that the first DB293 
molecule binds to ATGA, followed by a second molecule which binds with a higher binding constant 
than the first. NMR data has also shown that it binds in the minor groove as a dimer with an antiparallel 
stacking arrangement [95]. The interaction of DB293 with ATGA is clearly well-characterized and 
provides a good reference for a more complex system to study using ESI-MS. 
A set of titrations was performed using DB293 with four different DNA sequences. DB293 was found 
to form a 1:1 complex with AT-rich sites but also formed a dimer complex with the mixed GC-containing 
sequence ATGA. At low molar concentrations, the compound was shown to bind well with the AT-rich 
sequences but no formation of a complex with ATGA was observed. However, as the concentration of 
DB293 was increased, the formation of a 2:1 complex of compound to ATGA became apparent which 
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validates the positive, cooperative binding mode of DB293 since no 1:1 species was detected. The tallest 
peak observed corresponded to the DB293-ATGA complex and illustrated the preferred binding  
of DB293 with ATGA over interactions with AT-rich sequences as a 1:1 complex (see Figure 3c).  
The results found using ESI-MS agree well with other biophysical methods in both the relative binding 
affinities and binding modes of several well-studied DNA-small molecule interactions [96,97]. This 
study highlighted the ease of using several DNA sequences to simultaneously examine multiple interactions 
using a mixed set of DNA sequences and/or compounds. It also promoted competition among the ligands 
and DNAs which was determined by direct comparison of the peak intensities for the complexes and 
unbound DNAs. 
 
Figure 3. (a) Mixed hairpin DNA sequences used for ESI-MS studies, including a reference 
sequence; (b) ATGA-specific binding compound, DB293; (c) spectrum of DB293 with 
ATGA, ATATAT and AAATTT sequence binding sites. Unbound DNA remains unlabeled 
with corresponding color bar. Respective monomer complexes labeled with (*) for each 
titration. Dimer complexes (i.e., 2 to 1 stoichiometry) labeled as (**). Ratio shown is a molar 
concentration ratio of [4 to 1]. T = thymidine; A = adenosine; G = guanidine; C = cytidine. 
5.2.1. DNA and Analogs of DB293 
Competition ESI-MS was used to screen for relative binding of multiple compounds with a set of 
DNA sequences. The first set of studies followed the same approach where multiple DNA sequences 
and a single compound are screened for binding. Due to the extensive knowledge of DB293, it was used 
as a reference for the interaction of several DB293 analogs with a mixture of AT-rich and mixed-base 
pair sequences [71,80]. The set of titration experiments performed showed functional group modifications 
and structural variations influence minor groove binding (Figure 4). For instance, elongating the shape 
of DB293 inhibits dimer formation with the ATGA sequence and/or binding altogether. Slightly modifying 
the central five-membered ring through rearrangement and replacement of key hydrogen bond 
donor/acceptors also influences dimer formation of the compound with ATGA. The striking similarity 
among many of the structures, as shown in Figures 4 and 5, would have suggested that their interactions 
with ATGA would be the very similar; however, significant differences in the binding modes were found 
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with the ESI-MS method. Interestingly, the method also identified a new binding site for the dimer 
formation of one of the DB293 analogs with the reference sequence, CTGA, as denoted with (*)  
in Figure 5c. This sequence was initially used as a control or internal standard since it was believed  
to have no binding sites. These results raised two critical questions: (1) How did a seemingly simple 
reconfiguration of the central imidazole have such a large effect on the cooperative binding of DB2195 
and DB940 with the ATGA target site and (2) how did it allow DB940 to cooperatively bind with  
the CTGA sequence? Using ab initio calculations, optimized structures of the isomers suggest the less 
cooperative DB2195 has a 20° twist in the phenyl-imidazole torsional angle. On the other hand, the 
placement of the imidazole nitrogens near the benzimidazole in DB940 allows for a planar structure,  
similar to DB293, and inherently allows better stacking in the minor groove. Without ESI-MS,  
this serendipitous discovery would not have been made. It provided insight into recognition of a  
more mixed-sequence site and inspired a new competition ESI-MS approach: screening for interaction 
of a compound with DNA having a known target site along with a family of mutated target site sequences. 
 
Figure 4. Functional group modifications to the DB293 parent compound. Elongation of the 
phenyl (Ph) binding site by inclusion of a benzimidazole (Bnz) motif, highlighted in red. 
Substitution of the benzimidazole (Bnz) group for indole, shown blue. To the right in purple, 
substitution of the central furan (F) group for azole moieties: pyrrazole and imidazole. 
Diamidine (Am+) functional groups were maintained for all groups. Ph = phenyl;  
Bnz = benzimidazole; F = furan; Am+ = amidine. 
5.2.2. DB293 with ATGA and Mutant ATGA Sequences 
A second, more sophisticated approach examines the competitive binding of a single compound  
with a DNA having a known target site against multiple, mutated target sites. The mutational selection 
of sequences modified in this way allows a focused approach to determining the optimum recognition 
site for any compound with DNA. Discovery of the new CTGA binding site mentioned above illustrates  
the power of using ESI-MS to examine DNA small molecule interactions focused around a specific 
sequence. The second approach was adopted to investigate sequence-specific binding of a compound 
with DNA sequence variants and to determine cooperative interactions. This assay used a known target 
site along with a set of mutated DNA binding sites, in addition to a pure GC sequence as the reference 
sequence. It was determined that the consensus ATGA sequence was the optimal recognition site for 
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DB293 and agreed with earlier DNase I footprinting and other biophysical methods which identified 
ATGA as the target site [95]. 
 
Figure 5. (a) Mixed hairpin DNA sequences used for ESI-MS studies, including a reference 
sequence; (b) spectrum of ATGA, ATATAT and AAATTT sequence binding sites with the 
DB293 analog, DB2195; (c) spectrum of ATGA, ATATAT and AAATTT sequences with 
the analog DB940. Unbound DNA remains unlabeled with corresponding color bar. 
Respective monomer complexes labeled with (*) for each titration. Dimer complexes  
(i.e., 2 to 1 stoichiometry) labeled as (**). Molar concentration ratios for compound to DNA 
are [4 to 1]. T = thymidine; A = adenosine; G = guanidine; C = cytidine. 
A comparison of the consensus site with sequence variants offered insight into the effects the DNA 
sequence has on small molecule recognition (Figure 6). The importance of the TG critical sequence to 
binding is illustrated by the lack of complex formation with AGTA (yellow). The other sequences all 
formed both monomer and dimer complexes indicating lower positive cooperativity then with ATGA 
where no monomer binding is observed. Interestingly, the TTGA (pink) sequence has high positive 
cooperativity with little monomer binding while the sequence isomer, ATGT (blue), has little positive 
cooperativity. Because of this study, the importance of (i) functional group effects on minor groove 
recognition; (ii) identification of sequence specificity for a ligand with an optimal binding site; and  
(iii) the influence of DNA sequence on binding cooperativity were highlighted. The components which  
make DB293 ideal for recognition with ATGA were pinpointed. Additionally, the study provided a better 
understanding of how critical the sequence is even when the base pair composition is maintained, 
offering a new paradigm for DNA minor groove recognition. 
5.3. Using Competition to Study Complex, Mixed-Site Sequences with Minor Groove Binding Compounds 
A fairly recent study, which also incorporated competition ESI-MS, examined recognition of longer 
and more specific minor groove target sites. These sites were expanded to include two, separate AT-rich 
sites flanking one or two GC base pairs. Since many minor groove binding compounds are specific for 
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pure AT base pair containing sequences, this study represented a breakthrough in the development  
of more specific DNA recognizing compounds. This approach is important for therapeutic potential  
since increasing specificity should yield a concomitant decrease in toxicity or other side effects. DNA 
sequences were simultaneously screened with a small molecule to create an ideal competitive binding 
environment. Each sample contained a 100% GC base pair rich sequence (i.e., no AT base pairs) as an 
internal standard for better comparison of peak intensities. Molecular weights of the DNAs were adjusted 
so differences in the weights arose from substitution of an inosine for guanine (removing the C2 amino) 
in addition to modification of the hairpin loop. 
 
Figure 6. (a) The ATGA target base pair site for DB293; (b) ATGA-variant hairpin DNA 
sequences used for ESI-MS studies with preserved flanking base pair sequences, modified 
hairpin loops, and mutant target sites; (c) spectrum of unbound AGTA, ATGA, reference 
sequence, ATAA, ATGT and TTGA sequences; (d) spectrum of complexes formed between 
DB293 and ATAA, ATGT, TTGA and ATGA sequences. Unbound DNA is unlabeled with 
corresponding color bar. Respective monomer complexes labeled with (*) for each titration. 
Dimer complexes (i.e., 2 to 1 stoichiometry) labeled as (**). Molar concentration ratios for 
compound to DNA are [4 to 1]. T = thymidine; A = adenosine; G = guanidine; C = cytidine. 
The dicationic diamidine DB2120 (Figure 7) is a compound with a symmetric structure which 
contains two motifs known to binding AT-rich sites separated by a central pyridyl for potential G-base 
binding. Upon titrating in DB2120, all free A4GT4 was bound by the compound as a 1:1 complex.  
Only weak 1:1 complexes were formed between DB2120 with the DNA sequences containing none  
or two GC base pairs (i.e., A4T4 and A4GCT4) which clearly indicates the strong and very selective 
binding for the A4GT4 sequence (Figure 7). This is the first example of design of a minor groove binding 
agent for mixed base pair sequence recognition and ESI-MS was a key component in establishing the 
recognition sequence. Two analogs of DB2120 were next investigated, DB2119 and DB2370 (Figure 7). 
At a [4:1] molar concentration ratio of ligand to DNA, both analogs were found to interact weakly with 
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the two GC base pair sequence (A4GCT4). Each analog formed a complex with A4T4 and A4GT4 
sequences of similar relative intensities, which indicate neither DB2119 nor DB2370 can discriminate 
against zero or one GC base pair in the target site. The structure of DB2119 lacks a hydrogen bond 
acceptor, such as the pyridine nitrogen in DB2120, whereas DB2370 lacks the alkyl linker giving  
it a more rigid structure. The results obtained by ESI-MS for both analogs agree very well with 
biosensor-SPR, circular dichroism, modeling, and thermal melting studies [81]. 
 
Figure 7. (a) Mixed hairpin DNA sequences used for ESI-MS studies; (b) spectrum of A4T4 
and mixed sequences A4GT4 and A4GCT4 only; (c) spectrum of A4T4, A4GT4 and 
A4GCT4 sequences with DB2120; (d) spectrum of DNA sequences and DB2119;  
(e) spectrum of A4T4, A4GT4 and A4GCT4 sequences with DB2370. Unbound DNA 
remains unlabeled with corresponding color bar. Respective complexes labeled with (*) for 
each titration. Molar concentration ratios for compound to DNA are [4 to 1]. T = thymidine; 
A = adenosine; G = guanidine; C = cytidine. 
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6. Comparison of Mass Analyzers and Ionization Methods 
Analysis of whole or intact systems (e.g., DNA-complexes, apo- vs. holo- proteins, etc.) are critical 
to understanding the structural and functional properties of many biological systems. This becomes 
extremely important for analysis of low molecular weight binding compounds and during native MS of 
biomolecular systems. Considerations in the application of MS to study DNA-small molecule interactions 
include the type of instrument used for analysis. Hybrid quadrupole-time-of-flight (Q-ToF) mass analyzers 
are among the most widely used in mass spectrometry. The resolution, or resolving power, of a mass 
analyzer is characterized by its ability to distinguish neighboring ion peaks. The better the peak separation, 
the higher the resolution. The resolving power of time-of-flight (ToF) mass spectrometers are inherently 
poorer in comparison to quadrupole and orbitrap mass spectrometers, and while quadruple mass 
analyzers offer better resolution than time-of-flight, the resolving power of an orbitrap typically exceeds 
a hybrid Q-ToF mass spectrometer. 
For many DNA-small molecule studies, an ESI source with a hybrid Q-ToF mass analyzer gives 
adequate resolution for the system under study as well as reproducible results. In addition to ESI-Q-ToF, 
mass spectrometers with an ESI source and an orbitrap mass analyzer are becoming increasingly popular 
in the analysis of biomacromolecules. Both types of ESI mass spectrometers are powerful in the analysis 
of large biomolecules and are capable of scanning high molecular weight systems. An example comparing 
the results obtained, using two instruments containing an ESI source and outfitted with different mass 
analyzers, is shown below (Figure 8) and discussed in the following sections. 
In addition to ESI mass spectrometers, matrix assisted laser desorption ionization (MALDI) is a key 
technique in the analyses of biological systems. MALDI-MS begins by mixing the sample with a high 
proportion of matrix solution followed by spotting of the sample onto a specialized plate. After the 
solvent solution evaporates, the sample plate is inserted into the instrument for analysis. MALDI differs 
from ESI ionization in that radiation is used to remove the samples and matrix while simultaneously 
ionizing the molecules. Combined with a time-of-flight mass analyzer, MALDI has become a powerful 
tool in the analysis of biomacromolecules having molecular weights over 200 kDa and with high 
sensitivity [68]. Due to the high scanning capability and common practice in bioanalytical studies, an 
example of DNA-small molecule complexes analyzed using a MALDI-ToF mass spectrometer are 
shown in the following sections (Figure 9) to compare MALDI and ESI ionization sources. 
6.1. ESI-Q-ToF MS 
In Figure 8a, the sample containing DNA only (no netropsin) was labeled as “DNA only” and identified 
with blue peaks. The titration sample having equal molar ratios of netropsin to AAAAGCTTTT was 
labeled as “[1:1]” and shown with green peaks (Figure 8b). The final sample doubled the amount of 
netropsin to AAAAGCTTTT, bringing the ratio to [2:1] and labeled accordingly with red peaks  
(Figure 8c). Since there are two short AT-rich binding sites on the DNA (5′-AAAAGCTTTT-3′ and  
3′-TTTTCGAAAA-5′) of the size required for netropsin, one would expect to find 1:1 complexes  
at low concentrations of netropsin and 2:1 complexes at high netropsin concentrations. The tallest  
peak intensity in Figure 8a corresponds to DNA having a −6 charge to give m/z 1525  
(e.g., 9156 − 6 = 9150 ÷ 6 = 1525). The overall charge states of the DNA did not change when netropsin 
Int. J. Mol. Sci. 2015, 16 24522 
 
 
was added, so a −6 peak for a 1:1 binding complex of netrospin-DNA would be found near m/z 1595.  
A charge state of −6 was not the only charge present for the system. Net charges of −5 and −7 were also 
detected in the spectrum, but with less intensity compared to −6, regardless if the DNA was bound or 
not. From this set of spectra, it is clear netropsin binds more strongly as a 1:1 stoichiometric complex to 
AAAAGCTTTT and goes to 2:1 as the concentration of netropsin is increased. 
 
Figure 8. Comparison of spectra of DNA and complexes obtained using different mass 
analyzers. Peaks shown correspond to molar concentration ratios of [0:1], [1:1] and [2:1]  
for netropsin to DNA. Several negative charge states are shown ranging from −7 to −4. 
Stoichiometric ratios of 1:1 and 2:1 binding for netropsin to DNA are observed at the 
corresponding charge states. (a–c) Left column figures are for Q-ToF mass analyzer and  
(d–f) right column figures for orbitrap mass analyzer. Figures shown in blue (a,d) indicate 
DNA only in the sample mixture (no added netropsin). Those shown as green (b,e) are for 
molar concentration ratios of 1 to 1 (netropsin to DNA) and figures in red (c,f) correlate to 
molar concentration ratios of 2 to 1 (2 netropsin to 1 DNA). 
6.2. ESI-Orbitrap MS 
The third spectrum, Figure 8d, was analyzed by ESI using an orbitrap mass analyzer. An orbitrap 
mass analyzer can offer more features than the Q-ToF, such as higher mass resolution, accurate mass,  
a higher scanning range (m/z up to 6000 vs. 4000) [68] and less sample consumption. With this 
instrument, multiple NH4+ adducts with the DNA were found which lowered the sensitivity for any 
specific component, whereas nominal amounts of adducts were detected using the Q-ToF. A similar 
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problem was reported by Balthasart and co-workers with quadruplex DNA which sometimes traps a 
cation in the diagonal loop [99]. While hairpin duplex DNAs do not contain the same loops found in 
quadruplex structures, it is possible there may be an NH4+ cation contained within the DNA hairpin loop. 
A possible explanation for this is that the conditions used during Q-ToF analyses may be harsh enough 
to remove an ammonium ion compared to the orbitrap mass analyzer, so non-specifically bound NH4+ 
cations in the hairpin loop are lost during the Q-ToF analysis. Interestingly, the more abundant charge 
state detected by the orbitrap mass analyzer corresponded to the −6 charged species vs. −5 once netropsin 
was added with the Q-ToF. 
6.3. MALDI-ToF 
MALDI is useful for many reasons, including a scan range of up to 200,000 Da and can vaporize 
samples with relative ease. Samples having identical molar ratios of netropsin to AAAAGCTTTT were 
scanned. A deconvoluted spectrum of the samples analyzed using ESI-Q-ToF (Figure 9a) is compared 
with samples analyzed by MALDI-ToF (Figure 9b). Unfortunately, issues exist such as in order to 
retrieve and ionize the DNA complex, a laser with high intensity must be used to desorb the complex 
from the matrix surface. In doing so, the energy to desorb the analyte is often greater than the energy 
between the DNA and non-covalently bound small molecule. Similar results were observed when 
running MALDI to analyze samples of netropsin and AAAAGCTTTT and find that even with the lowest 
intensity possible, the energy is greater than that needed to form the complex and only free DNA is 
detected, even at the highest concentration of netropsin. 
 
Figure 9. Spectra of DNA-netropsin complexes analyzed by different ionization techniques. 
Peaks from the [0:1], [1:1] and [2:1] molar concentration ratios of netropsin to DNA were 
overlaid for simple comparison. (a) Deconvoluted spectrum of DNA and complexes ionized 
through electrospray and (b) full MALDI spectrum showing no detectable netropsin-DNA 
complexes at any ratio. 
There are other concerns in using MALDI to study DNA-small molecule interactions. For example, 
positive ion mode is intrinsically more sensitive in MS analyses but in MALDI-MS, nucleic acids often 
need to be in positive mode which poses a problem for high negatively charged species, such as DNA. 
Another issue is separation of the matrix and DNA-complexes during the drying process and crystallization 
of the matrix which creates heterogeneity in the sample. The “sweet spot”—a favorable, yet unknown 
formation of crystals containing the analyte—must be determined, but only after the loading plate has 
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been inserted into the instrument. Additionally, it is also possible interference with the DNA-small 
molecule complex occurs from the matrix and can cause the compound to dissociate from the DNA. The 
conditions used in MALDI are considerably harsher than those used in ESI and are particularly important 
when studying non-covalent interactions such as small molecule-DNA complexes. This is likely the 
reason for the disappearance of any netropsin-DNA complex peaks when using MALDI compared to 
analysis by ESI-Q-ToF and ESI-orbitrap mass spectrometers. 
The results obtained using an ESI source are consistent unlike those by MALDI. Both the ESI-Q-ToF 
and ESI-orbitrap instruments indicate the majority of DNA was bound to netropsin by [2:1] ratios with 
both 1:1 and 2:1 stoichiometric complexes. Riccardi-Sirtori and co-workers have shown similar findings 
in the analysis of DNA-small molecule complexes using both ESI-Q-ToF and ESI-orbitrap mass 
spectrometers [100]. Their results were comparable to each other based on the apparent binding constants 
determined using both instruments types and agree well with the results shown in Figure 8. Slight 
variability can exist in the relative peak intensities when using different mass analyzers. For instance, 
instrument parameters were optimized according to each instrument and the conditions necessary for 
ESI-orbitrap and ESI-Q-ToF mass spectrometers vary. Considering that there are differences even  
in identical instruments, many factors, even seemingly minor ones such as when the instrument was  
last tuned, calibration, even the time of day, can affect instrument performance. These factors should be 
considered in comparative studies of macromolecular systems but can be simplified when using 
competition ESI-MS. 
7. Conclusions 
ESI-MS has already been established as a powerful tool in the characterization of small molecules 
and biomacromolecular systems. Development of a competition ESI-MS method has allowed ESI-MS 
to be used as a high throughput screening technique to simultaneously investigate the binding interactions 
of minor groove binding compounds with multiple DNA sequences. Important information such as 
stoichiometry, relative binding affinities, cooperativity, and binding modes are easily determined with 
competition ESI-MS. Sample preparation is simple and analyses are quick which becomes especially 
important for sensitive systems including DNA-small molecule, DNA-protein, protein-protein, DNA-RNA 
hybrids, and protein-ligand complexes. This method is especially attractive since theoretically any 
number of interactions can be examined, as long as the molecular weights are distinguishable for both 
the free/unbound species and complexed systems. Additionally, inclusion of a reference or control 
system within the sample with which to compare system(s) of interest can allow the relative binding 
affinities to be determined. The results obtained by competition ESI-MS experiments offer clear spectral 
comparisons and reproducible results that are in agreement with other biophysical methods. 
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